Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,870.00    175.00 (2.61%)
Bid:
6,865.00
Ask:
6,875.00
Spread: 10.00 (0.146%)
Market Cap: £5.07b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Board Changes

31 Jan 2023 09:30

RNS Number : 8632L
Spirax-Sarco Engineering PLC
31 January 2023
 

 

 

 

31 January 2023

 

BOARD CHANGES

 

Spirax‑Sarco Engineering plc, the thermal energy management and niche pumping specialist, announces that Olivia Qiu, Non-Executive Director, has decided to step down from the Board for personal reasons as of 31 January 2023.

 

Jamie Pike, Chair of Spirax-Sarco Engineering, said: "On behalf of our shareholders, the Board acknowledges with gratitude Olivia's significant contribution since her appointment. We respect her decision to step back from some of her external commitments at this time and we wish her all the very best for her future".

 

In line with the succession planning undertaken by the Nomination Committee, we have initiated the process to appoint another Non-Executive Director with the skills and experience required to support the implementation of our strategies in line with our commitments to inclusion and diversity.

 

There are no further disclosures to be made pursuant to Listing Rule 9.6.13.

 

Enquiries:

 

Andy Robson, General Counsel

Tel: 01242 535276

 

About Spirax‐Sarco Engineering plc

Spirax‐Sarco Engineering plc is a thermal energy management and niche pumping specialist. It comprises three world‐leading Businesses: Steam Specialties, for the control and management of steam; Electric Thermal Solutions, for advanced electrical process heating and temperature management solutions; and Watson-Marlow, for peristaltic pumping and associated fluid path technologies. The Steam Specialties and Electric Thermal Solutions Businesses provide a broad range of fluid control and electrical process heating products, engineered packages, site services and systems expertise for a diverse range of industrial and institutional customers. Both Businesses help their end users to improve production efficiency, meet their environmental sustainability targets, improve product quality and enhance the safety of their operations. Watson‐Marlow provides solutions for a wide variety of demanding fluid path applications with highly accurate, controllable and virtually maintenance-free pumps and associated technologies.

 

The Group is headquartered in Cheltenham, UK, has strategically located manufacturing plants around the world and employs over 10,000 people, including more than 2,000 direct sales and service engineers. The Company's shares have been listed on the London Stock Exchange since 1959 (symbol: SPX) and it is a constituent of the FTSE 100 and the FTSE4Good indices.

 

Further information can be found at www.spiraxsarcoengineering.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUVOBROOUARAR
Date   Source Headline
1st Jun 20169:45 amRNSTotal Voting Rights
31st May 20165:22 pmRNSDirector Declaration
10th May 20164:48 pmRNSResult of AGM
10th May 20167:00 amRNSAGM Statement - Trading Update
6th May 20169:46 amRNSTotal Voting Rights
6th May 20169:45 amRNSHolding(s) in Company
6th May 20169:45 amRNSHolding(s) in Company
15th Apr 20162:00 pmRNSDirector/PDMR Shareholding
24th Mar 20164:38 pmRNSDirector/PDMR Shareholding
22nd Mar 201611:21 amRNSTotal Voting Rights
21st Mar 20162:15 pmRNSAnnual Report 2015 & Notice of AGM
15th Mar 201610:11 amRNSDisclosure of Home Member State
9th Mar 201612:34 pmRNSDirector/PDMR Shareholding
3rd Mar 20167:00 amRNSFinal Results 2015
23rd Feb 201611:05 amRNSTotal Voting Rights
29th Jan 20169:10 amRNSBlocklisting Interim Review
22nd Jan 20168:21 amRNSTotal Voting Rights
6th Jan 201612:36 pmRNSHolding(s) in Company
22nd Dec 20159:27 amRNSTotal Voting Rights
8th Dec 201510:21 amRNSHolding(s) in Company
3rd Dec 201511:09 amRNSDirector/PDMR Shareholding
2nd Dec 20158:18 amRNSHolding(s) in Company
26th Nov 20152:01 pmRNSHolding(s) in Company
26th Nov 20151:58 pmRNSHolding(s) in Company
25th Nov 20159:00 amRNSAcquisition
24th Nov 20152:50 pmRNSHolding(s) in Company
23rd Nov 20151:31 pmRNSTotal Voting Rights
19th Nov 20153:18 pmRNSHolding(s) in Company
19th Nov 20153:13 pmRNSHolding(s) in Company
17th Nov 20157:00 amRNSTrading Update
10th Nov 20152:38 pmRNSDirector/PDMR Shareholding
6th Nov 20152:25 pmRNSAdditional Listing
2nd Nov 20153:27 pmRNSAdditional Listing
30th Oct 20151:20 pmRNSDirector Declaration
27th Oct 20157:00 amRNSDirectorate Change
21st Oct 20151:57 pmRNSTotal Voting Rights
13th Oct 201512:23 pmRNSDirector/PDMR Shareholding
9th Oct 201511:47 amRNSDoc re. Key Dates
9th Oct 201510:57 amRNSAdditional Listing
5th Oct 201511:47 amRNSHolding(s) in Company
28th Sep 20152:00 pmRNSAcquisition
16th Sep 201511:07 amRNSDirector/PDMR Shareholding
15th Sep 20153:42 pmRNSTotal Voting Rights - Replacement
15th Sep 20153:02 pmRNSTotal Voting Rights
9th Sep 201512:00 pmRNSCompliance with Model Code
8th Sep 201511:45 amRNSHolding(s) in Company
28th Aug 201510:18 amRNSDirector/PDMR Shareholding
26th Aug 20153:33 pmRNSDirector/PDMR Shareholding
5th Aug 20157:00 amRNSHalf Year Results
4th Aug 20157:00 amRNSDisposal

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.